4 articles

TED@UPS: Could Biology Cure Traffic Congestion?

What if traffic flowed through our streets as smoothly and efficiently as blood flows through our veins? Wanis Kabbaj sits down for a Q&A.

In September, UPS Healthcare Strategy Director Wanis Kabbaj gave a TED@UPS talk. Longitudes caught up with him recently to talk about the experience and what he hopes people might learn from his presentation. His talk is being featured on TED.com – click the link below to view. Afterwards, check out our Q&A with Wanis below. Q. […]

Offset Cold Chain Complexities with Creativity

Pharmaceutical innovations aren’t slowing down, so why should smart logistics?

In entertainment, late filmmaker Cecil B. DeMille once said, “Creativity is a drug I cannot live without.” The same can be said in healthcare about today’s 7 billion global healthcare consumers, who are living longer, have better access to quality care, and are demanding more choices, more convenience and better outcomes. It’s an evolving paradigm, […]

The New World Order in Transportation

Transportation innovation and economic growth are inextricably linked. Without innovation, economic growth is not possible.

In an increasingly congested world, the transportation industry is up against unrelenting pressure to facilitate the free flow of goods. Traffic congestion in cities worldwide is a major problem. Unfortunately, the issue is compounding as cities grow and car ownership rates increase. However, there are numerous opportunities for forward-looking companies capable of delivering solutions to […]

The High Stakes in “Cold Chain”

Market changes are driving pharmaceutical companies to consider new ways to mitigate risk in the cold chain.

A growing global middle class, longer supply chains, and the launch of new, innovative healthcare products are putting more complex demands on the pharmaceutical industry’s high-stakes logistics environment. Factors such as new, temperature-sensitive biologics, increasing cold-chain regulations, and growing cost pressures require pharmaceutical executives to reconsider how they prioritize “cold” supply-chain decisions. Strategies such as […]